Knowledge (XXG)

Lys-MDA

Source 📝

239: 29: 345: 326: 303: 41: 343:, Clark S, Duncton MA, "Methylenedioxymethamphetamine and Related Psychedelics and Uses Thereof", published 12 January 2023, assigned to Terran Biosciences Inc. 340: 563: 178: 324:, Grill M, "Novel Safrylamine derivatives having prodrug properties.", published 17 March 2022, assigned to Compass Pathfinder Limited. 960: 991: 568: 612: 553: 377: 223:
with a slower onset of effects and longer duration of action. Lys-MDA, along with the related derivative Lys-MDMA, are in early stage human
1006: 600: 996: 164: 476: 774: 471: 285: 65: 543: 232: 228: 917: 764: 617: 513: 508: 481: 461: 321: 595: 416: 965: 804: 746: 394: 370: 220: 446: 1001: 945: 937: 714: 466: 441: 436: 431: 411: 208: 970: 950: 927: 909: 304:"MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances" 955: 922: 839: 831: 451: 386: 259: 854: 844: 726: 363: 426: 421: 82: 1011: 91: 254: 107: 743: 721: 224: 243: 985: 588: 523: 518: 503: 456: 264: 238: 879: 864: 573: 235:. New MDMA prodrugs are in the development phase at MiHKAL GmbH in Switzerland. 28: 889: 884: 496: 212: 140: 894: 849: 355: 874: 869: 859: 20: 799: 702: 690: 685: 655: 650: 538: 216: 899: 697: 680: 675: 670: 660: 645: 640: 635: 625: 578: 821: 811: 784: 759: 733: 665: 630: 583: 533: 528: 237: 163: 154: 816: 794: 789: 779: 769: 709: 605: 558: 488: 359: 286:"MindMed announces Phase 1 study of MDMA-like substances" 623:
Benzofurans, dihydrobenzofurans and benzothiophenes:
936: 908: 830: 742: 393: 152: 139: 106: 101: 81: 56: 40: 35: 205:N-(L-lysinamidyl)-3,4-methylenedioxyamphetamine 90: 371: 8: 19: 378: 364: 356: 27: 276: 183: 70: 18: 7: 14: 186:CC(Cc2ccc1OCOc1c2)NC(=O)C(N)CCCCN 124: 118: 594:1-Phenylbutan-2-amines: {  992:Drugs not assigned an ATC code 290:Drug Discovery and Development 233:post-traumatic stress disorder 229:treatment-resistant depression 130: 112: 1: 284:Buntz B (21 September 2022). 73:(2S)-2,6-diamino-N-hexanamide 227:as potential treatments for 1007:Entactogens and empathogens 1028: 102:Chemical and physical data 215:effects, which acts as a 174: 61: 26: 997:Substituted amphetamines 946:Substituted amphetamine 514:3,4-MDA (tenamfetamine) 495:Phenethylamine: {  387:Empathogens/entactogens 209:substituted amphetamine 245: 611:Phentermines: {  559:MDMA (midomafetamine) 502:Amphetamines: {  409:Unfused benzene ring: 260:Serdexmethylphenidate 241: 727:Naphthylaminopropane 310:. 20 September 2022. 23: 246: 979: 978: 194: 193: 165:Interactive image 16:Chemical compound 1019: 938:Chemical classes 380: 373: 366: 357: 350: 349: 348: 344: 337: 331: 330: 329: 325: 318: 312: 311: 300: 294: 293: 281: 255:Lisdexamfetamine 211:derivative with 167: 147: 132: 126: 120: 114: 94: 31: 24: 22: 1027: 1026: 1022: 1021: 1020: 1018: 1017: 1016: 982: 981: 980: 975: 971:Sub. tryptamine 951:Sub. benzofuran 932: 904: 826: 809:Aminotetralins: 807: 748: 738: 729: 717: 705: 693: 621: 491: 484: 401: 399: 396: 389: 384: 354: 353: 346: 339: 338: 334: 327: 320: 319: 315: 302: 301: 297: 283: 282: 278: 273: 251: 225:clinical trials 190: 187: 182: 181: 170: 145: 135: 129: 123: 117: 97: 77: 74: 69: 68: 52: 17: 12: 11: 5: 1025: 1023: 1015: 1014: 1009: 1004: 1002:Designer drugs 999: 994: 984: 983: 977: 976: 974: 973: 968: 963: 958: 956:Sub. cathinone 953: 948: 942: 940: 934: 933: 931: 930: 925: 920: 914: 912: 906: 905: 903: 902: 897: 892: 887: 882: 877: 872: 867: 862: 857: 852: 847: 842: 836: 834: 828: 827: 825: 824: 819: 814: 802: 797: 792: 787: 782: 777: 772: 767: 762: 753: 751: 740: 739: 737: 736: 724: 722:Methamnetamine 712: 700: 688: 683: 678: 673: 668: 663: 658: 653: 648: 643: 638: 633: 628: 615: 609: 603: 598: 592: 586: 581: 576: 571: 566: 561: 556: 551: 546: 541: 536: 531: 526: 521: 516: 511: 506: 500: 493:Benzodioxoles: 479: 474: 469: 464: 459: 454: 449: 444: 439: 434: 429: 424: 419: 414: 405: 403: 391: 390: 385: 383: 382: 375: 368: 360: 352: 351: 341:WO 2023/283373 332: 322:WO 2022/053696 313: 295: 275: 274: 272: 269: 268: 267: 262: 257: 250: 247: 192: 191: 189: 188: 185: 177: 176: 175: 172: 171: 169: 168: 160: 158: 150: 149: 143: 137: 136: 133: 127: 121: 115: 110: 104: 103: 99: 98: 96: 95: 87: 85: 79: 78: 76: 75: 72: 64: 63: 62: 59: 58: 54: 53: 51: 50: 46: 44: 38: 37: 33: 32: 15: 13: 10: 9: 6: 4: 3: 2: 1024: 1013: 1010: 1008: 1005: 1003: 1000: 998: 995: 993: 990: 989: 987: 972: 969: 967: 964: 962: 959: 957: 954: 952: 949: 947: 944: 943: 941: 939: 935: 929: 926: 924: 921: 919: 916: 915: 913: 911: 907: 901: 898: 896: 893: 891: 888: 886: 883: 881: 878: 876: 873: 871: 868: 866: 863: 861: 858: 856: 853: 851: 848: 846: 843: 841: 838: 837: 835: 833: 829: 823: 820: 818: 815: 813: 810: 806: 803: 801: 798: 796: 793: 791: 788: 786: 783: 781: 778: 776: 773: 771: 768: 766: 763: 761: 758: 757:Aminoindanes: 755: 754: 752: 750: 745: 741: 735: 732: 728: 725: 723: 720: 719:Naphthalenes: 716: 713: 711: 708: 704: 701: 699: 696: 692: 689: 687: 684: 682: 679: 677: 674: 672: 669: 667: 664: 662: 659: 657: 654: 652: 649: 647: 644: 642: 639: 637: 634: 632: 629: 627: 624: 619: 616: 614: 610: 607: 604: 602: 599: 597: 593: 590: 587: 585: 582: 580: 577: 575: 572: 570: 567: 565: 562: 560: 557: 555: 552: 550: 547: 545: 542: 540: 537: 535: 532: 530: 527: 525: 522: 520: 517: 515: 512: 510: 507: 505: 501: 498: 494: 490: 487: 486:Benzodioxine: 483: 480: 478: 475: 473: 470: 468: 465: 463: 460: 458: 455: 453: 450: 448: 445: 443: 440: 438: 435: 433: 430: 428: 425: 423: 420: 418: 415: 413: 410: 407: 406: 404: 398: 392: 388: 381: 376: 374: 369: 367: 362: 361: 358: 342: 336: 333: 323: 317: 314: 309: 305: 299: 296: 291: 287: 280: 277: 270: 266: 263: 261: 258: 256: 253: 252: 248: 244: 240: 236: 234: 230: 226: 222: 218: 214: 210: 206: 202: 198: 184: 180: 173: 166: 162: 161: 159: 156: 151: 144: 142: 138: 111: 109: 105: 100: 93: 89: 88: 86: 84: 80: 71: 67: 60: 55: 48: 47: 45: 43: 39: 36:Clinical data 34: 30: 25: 918:4-Methyl-αET 808: 756: 730: 718: 706: 694: 622: 589:N-t-BOC-MDMA 548: 524:6-Methyl-MDA 519:5-Methyl-MDA 504:2-Methyl-MDA 492: 485: 457:Metaescaline 408: 395:Phenylalkyl- 335: 316: 308:Biospace.com 307: 298: 289: 279: 265:N-t-BOC-MDMA 213:empathogenic 204: 200: 196: 195: 92:1391487-26-5 910:Tryptamines 880:Flephedrone 865:Dimethylone 855:Brephedrone 749:alkylamines 402:cathinones) 400:(other than 148: g·mol 57:Identifiers 986:Categories 961:Sub. MDPEA 890:Methedrone 885:Mephedrone 832:Cathinones 497:Lophophine 271:References 201:Lysine-MDA 153:3D model ( 141:Molar mass 83:CAS Number 66:IUPAC name 895:Methylone 850:BK-5-MAPB 731:Tetralin: 447:4,4'-DMAR 242:Lys-MDMA 1012:Prodrugs 966:Sub. PEA 875:Eutylone 870:Ethylone 860:Butylone 744:Cyclized 707:Indoles: 695:Indanes: 249:See also 42:ATC code 800:NM-2-AI 747:phenyl- 703:5-MAPDI 691:IBF5MAP 686:6-MAPDB 656:5-MAPBT 651:5-MAPDB 620: } 608: } 591: } 549:Lys-MDA 539:DMMDA-2 509:2,3-MDA 499: } 452:Ariadne 217:prodrug 207:) is a 197:Lys-MDA 146:307.394 108:Formula 21:Lys-MDA 900:TH-PVP 698:5-APDI 681:6-MAPB 676:6-EAPB 671:6-APDB 661:5-MBPB 646:5-MAPB 641:5-EAPB 636:5-APDB 626:2-MAPB 579:MMDA-2 397:amines 347:  328:  179:SMILES 845:4-EMC 840:3-MMC 822:MDMAT 812:6-CAT 785:MDMAI 760:5-IAI 734:6-APT 715:6-API 666:6-APB 631:5-APB 584:MMDMA 564:MDMOH 534:DMMDA 529:DFMDA 442:4-MTA 437:4-FMA 432:4-MMA 417:4-CAB 412:3-CMA 155:JSmol 817:MDAT 795:MEAI 790:MMAI 780:MDAI 775:ETAI 770:BFAI 765:AMMI 710:5-IT 618:MDPH 613:MDMP 606:MBDB 601:EBDB 574:MMDA 569:MDOH 554:MDEA 544:EIDA 489:EDMA 482:mMMA 477:PMMA 472:PMEA 427:4-MA 422:4-FA 231:and 219:for 49:none 928:αMT 923:αET 805:TAI 596:BDB 467:PMA 462:MMA 221:MDA 988:: 306:. 288:. 203:, 122:25 116:16 379:e 372:t 365:v 292:. 199:( 157:) 134:3 131:O 128:3 125:N 119:H 113:C

Index


ATC code
IUPAC name
CAS Number
1391487-26-5
Formula
Molar mass
JSmol
Interactive image
SMILES
substituted amphetamine
empathogenic
prodrug
MDA
clinical trials
treatment-resistant depression
post-traumatic stress disorder


Lisdexamfetamine
Serdexmethylphenidate
N-t-BOC-MDMA
"MindMed announces Phase 1 study of MDMA-like substances"
"MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances"
WO 2022/053696
WO 2023/283373
v
t
e
Empathogens/entactogens

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.